Glisoxepide (INN) is an orally available anti-diabetic drug from the group of sulfonylureas.

[1] It belongs to second-generation sulfonylureas.

[2] This drug article relating to the gastrointestinal system is a stub.

You can help Wikipedia by expanding it.